Organon & Return on Equity (ROE) Growth & History (OGN)

Organon &'s return on equity was 30.56% for fiscal 2025.

View full Organon & company overview

Organon & annual return on equity history

Organon & annual return on equity

Fiscal yearPeriod endedReturn on equityChange (percentage points)
20252025-12-3130.56%−399.30 pp
20242024-12-31429.85%
20212021-12-3167.92%+33.42 pp
20202020-12-3134.50%

Organon & return on equity trends

Over the last five fiscal years, Organon &'s return on equity decreased from 34.50% to 30.56%, a change of −3.95 percentage points. The latest reported quarter, Q2 2026, shows 11.31%.

About the metric

What return on equity (ROE) means

Return on equity (ROE) measures how much net income a company generates relative to shareholders’ equity. It can help evaluate how efficiently equity capital is used, but unusually high or negative values may reflect leverage, losses, or a small equity base.

Calculation and source

How return on equity is calculated

TickerStat calculates ROE as SEC-reported net income divided by average stockholders’ equity at the beginning and end of the fiscal period. Periods with missing or non-positive average equity are omitted. Quarterly ROE uses quarterly net income and is not annualized. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Organon & source filings ↗

Community posts

It’s quiet here.

No posts about OGN yet. Start the conversation.

Write the first post